P-Selectin Glycoprotein Ligand-1 Forms Dimeric Interactions with E-Selectin but Monomeric Interactions with L-Selectin on Cell Surfaces by Zhang, Yan et al.
P-Selectin Glycoprotein Ligand-1 Forms Dimeric
Interactions with E-Selectin but Monomeric Interactions
with L-Selectin on Cell Surfaces
Yan Zhang1¤a, Ning Jiang2¤b, Veronika I. Zarnitsyna2, Arkadiusz G. Klopocki3, Rodger P. McEver3,4,
Cheng Zhu1,2*
1Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States of America, 2Coulter Department of Biomedical
Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States of America, 3Cardiovascular Biology Research Program, Oklahoma Medical Research
Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America, 4Department of Biochemistry & Molecular Biology,
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America
Abstract
Interactions of selectins with cell surface glycoconjugates mediate the first step of the adhesion and signaling cascade that
recruits circulating leukocytes to sites of infection or injury. P-selectin dimerizes on the surface of endothelial cells and forms
dimeric bonds with P-selectin glycoprotein ligand-1 (PSGL-1), a homodimeric sialomucin on leukocytes. It is not known
whether leukocyte L-selectin or endothelial cell E-selectin are monomeric or oligomeric. Here we used the micropipette
technique to analyze two-dimensional binding of monomeric or dimeric L- and E-selectin with monomeric or dimeric PSGL-
1. Adhesion frequency analysis demonstrated that E-selectin on human aortic endothelial cells supported dimeric
interactions with dimeric PSGL-1 and monomeric interactions with monomeric PSGL-1. In contrast, L-selectin on human
neutrophils supported monomeric interactions with dimeric or monomeric PSGL-1. Our work provides a new method to
analyze oligomeric cross-junctional molecular binding at the interface of two interacting cells.
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Introduction
During acute inammation, leukocytes are recruited from the
circulation to sites of infection and injury. This multistep adhesion
and signaling cascade is initiated by interactions between selectins
and their glycoconjugates that mediate leukocyte tethering to and
rolling on the surface of endothelial cells [1]. The selectin family
includes three members. L-selectin is expressed on leukocytes. P-
and E-selectin are expressed on activated platelets and/or
activated endothelial cells. Their common structure includes
a ligand-binding lectin domain, an epidermal growth factor-like
module, multiple copies of consensus repeats characteristic of
complement-binding proteins, a transmembrane segment, and
a short cytoplasmic domain [1–3]. The best characterized selectin
ligand is P-selectin glycoprotein ligand-1 (PSGL-1), a high-affinity
ligand for P-selectin that also binds to L- and E-selectin [1–3].
P-selectin [4,5] and PSGL-1 [6–8] form dimers on the
respective surfaces of endothelial cells and leukocytes. Dimeriza-
tion of P-selectin and PSGL-1 stabilizes cell rolling and enhances
tether strength in shear flow [9] and prolongs bond lifetime [10].
Induced cell-surface dimerization of L-selectin by cross-linking its
cytoplasmic or extracellular domains increases binding to soluble
ligand mimic and adhesion to immobilized ligand or to vascular
endothelium under shear [11,12]. However, biochemical analyses
of the L-selectin transmembrane and cytoplasmic domains suggest
that they are monomeric in bacterial or synthetic membranes [13].
PSGL-1 does not form dimeric bonds with E-selectin purified from
lysates of CHO cell transfectants after it is reconstituted into glass-
supported lipid bilayers [14]. However, it is not known whether E-
selectin forms monomers or oligomers on the surfaces of
endothelial cells.
Like other cell adhesion receptors, selectins and their ligands
also transduce signals [1,15]. Antibody-mediated crosslinking of L-
selectin or PSGL-1 on leukocytes or of E- or P-selectin on
endothelial cells triggers intracellular calcium fluxes and protein
tyrosine phosphorylation. Receptor tyrosine kinases [16] and
multichain immune recognition receptors [17] must form dimers
to transduce signals. On the other hand, both dimeric and
monomeric forms of PSGL-1 transduce signals after engaging P-
selectin [18]. Whether other selectin ligands or selectins themselves
must dimerize to signal under physiological conditions is not
known.
The goal of the present work was to determine whether L- and
E-selectin form oligomers or monomers on cell surfaces. We used
the micropipette adhesion frequency assay to analyze two-
dimensional (2D) binding between selectins and ligands [19–22].
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Our strategy was to use purified molecular systems with
structurally well-defined multimericities to define the requirements
and properties of monomeric and dimeric interactions between the
same receptor-ligand pair. By comparing binding to the same
densities of native dimeric PSGL-1 and recombinant monomeric
soluble (s) PSGL-1 [10], we showed that endothelial cell E-selectin




Chinese hamster ovary (CHO) cells transfected to stably express
human E-selectin were previously described [23]. Human aortic
endothelial cells (HAECs, Clonetics, Walkersville, MD) were
generous gifts from Dr. Julia Babensee (Georgia Institute of
Technology) and were maintained as previously described [24].
CHO cells were cultured in RPMI 1640 plus 5% fetal bovine
serum, 5% calf serum, 2 mM glutamine, 1 mM sodium pyruvate,
and 1% penicillin/streptomycin. To induce expression of E-
selectin, HAECs were stimulated with 100 U/ml interleukin-1b
(IL-1b) for 6 h.
Neutrophils were isolated from a drop of whole blood via
a finger prick and RBCs were isolated from peripheral blood
drawn from healthy volunteers according to protocols approved by
Georgia Institute of Technology’s Institutional Review Board [25].
Written informed consent were obtained for all volunteers.
Neutrophils were prepared on the day of experiment. After RBCs
were lysed by a brief hypotonic shock, neutrophils were spun down
and resuspended in Hanks’ balanced salt solution (Sigma-Aldrich,
St. Louis, MO) with 1% human serum albumin (ZLB Plasma,
Boca Raton, FL), and used immediately. RBCs were prepared and
stored for experiments in several weeks. Whole blood was layered
over Histopaque 1119 (Sigma) and centrifuged by 2000 g for
30 min at room temperature. The pelleted RBCs were washed,
coated with capturing antibodies, and stored in experimental
additive solution 45 (EAS 45) (Dumaswala et al., 1996) at 4uC.
Human L-selectin-Ig was expressed and purified as previously
described [26]. The same methods were used to construct, express,
and purify human E-selectin-Ig, comprising the lectin and
epidermal growth factor domains and the first two consensus
repeats of human E-selectin fused to the Fc portion of human
IgG1. Recombinant human sE-selectin [27], sPSGL-1 [28],
membrane PSGL-1 [8], anti-E-selectin capturing and blocking
monoclonal antibodies (mAbs) 1D6 [29] and ES1 [23], anti-L-
selectin mAb DREG56 [30], and anti-PSGL-1 capturing mAb
PL2 [31] have been described previously. Goat anti-human IgG
antibody (for capturing selectin-Ig) and FITC-labeled goat anti-
mouse IgG mAb A85-1 (used as secondary antibody) or FITC-
labeled human IgG antibody (for site density measurement) was
from Sigma. PE-labeled anti-PSGL-1 mAb PL1 for site density
measurement was from Calbiochem (St. Louis, MO).
Coupling Ligands onto RBC Surface
A previously described modified chromium chloride (CrCl3)
method [32] was used to couple capturing antibodies (1D6 for sE-
selectin, goat anti-human IgG-Fc for L- and E-selectin-Ig, and PL2
for (s)PSGL-1) on RBC. Briefly, a 1% CrCl3 solution was
prepared, aged at pH 5, and diluted in 20 mM acetate-buffered
saline, pH 5.5, at ratios ranging from 1:100 to 1:2400. RBCs were
washed five times in saline and resuspended in 1% hematocrit.
Antibodies were added to each 250 ml sample and mixed. An
equal volume of diluted CrCl3 solution was added dropwise with
constant agitation. After 5 min the reaction was stopped by
addition of 0.5 ml phosphate buffered saline plus 1% IgG-free
bovine serum albumin (BSA). Aliquots from each sample were
examined under light microscopy for aggregation. Cells were
subsequently washed and stored in EAS45. Immediately prior to
the micropipette experiment, RBCs precoated with 1D6, anti-Fc
or PL2 were respectively incubated with sE-selectin (0.5 mg/ml),
L- or E-selectin-Ig (0.5 mg/ml), or (s)PSGL-1 (0.2 mg/ml) at room
temperature for 30 min.
Micropipette Adhesion Frequency Assay
A previously described micropipette adhesion frequency assay
[19–22] was used to analyze the two-dimensional (2D) binding
between various forms of L- or E-selectin and (s)PSGL-1. Briefly,
a cell chamber filled with 3 ml of L-15 medium supplemented with
1% BSA was mounted on the stage of an inverted microscope
(Zeiss Axiovert 100, Oberkochan, Germany). Cells coated with
selectins or ligands were added to different locations separated by
sufficient distance to avoid mixing. A selectin-coated cell was
picked up by one micropipette and a ligand-coated cells was
picked up by an apposing micropipette. The cells were then
aligned via micromanipulation. Selectins were either captured on
RBCs by precoated antibodies (Fig. 1C), expressed on human
neutrophils (for L-selectin, Fig. 1D), or expressed on CHO cell
transfectants or induced on HAECs (for E-selectin, Fig. 1E).
(s)PSGL-1 was captured on RBCs by precoated mAb (Fig. 1F).
One pipette was driven by a computer-controlled piezo translator
to move the cell to contact the other cell held stationary for a pre-
determined area and duration. Following pipette retraction, the
cells were either immediately separated (no adhesion, scored 0) or
remained bound with the exible RBC(s) being stretched (adhesion,
scored 1) for a short time until detachment. The likelihood of
adhesion was estimated from the frequency of adhesions (Pa)
observed in 50,100 repeated contact cycles using a single pair of
cells. Three to five cell pairs were tested to obtain a mean Pa 6
S.E.M. for that contact duration (t). Measurements were made in
five contact durations to obtain a Pa vs. t binding curve for each
receptor-ligand pair respectively expressed on the corresponding
cells at given site densities measured separately by flow cytometry.
Site Density Determination
Cell samples were incubated with saturating concentrations of
fluorescence-conjugated primary antibodies (10 mg/ml or accord-
ing to manufacturer’s instruction) in FACS solution (RPMI with
1% BSA and 0.05% sodium azide) for 30 min followed by three
washes, and analyzed immediately. If non-conjugated primary
antibody was used, cells were next incubated with FITC-
conjugated secondary antibody (10 mg/ml or per manufacturer’s
instruction) and then washed and analyzed immediately. Cells and
calibration beads from quantum FITC MESF kits (Bangs
Laboratories, Fishers, IN) were analyzed on a BD LSR II flow
cytometer (Becton-Dickinson Immunocytometry Systems, San
Jose, CA). The mean fluorescent intensities (MFIs) were recorded
for samples as well as for each peak of the calibration beads. A
standard curve was plotted using the MFIs of the calibration
beads, which was used to calculate molecules of equivalent soluble
fluorophore (MESF) from the MFIs measured from the cells.
Antibodies bound per cell were then calculated by dividing MESF
by fluorophore per antibody (supplied by manufacturers), which
were then converted to site densities by dividing by the cell surface
area [33,34].
The capacity of capturing E- or L-selectin-Ig by goat anti-
human IgG antibody precoated on RBCs was measured using
a FITC-conjugated human IgG. At saturating concentration, each
binding site for Fc should capture one dimeric E- or L-selectin-Ig.
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Direct measurement using anti-E-selectin (ES1) and anti-L-selectin
(DREG56) mAbs obtained similar results. The site density of sE-
selectin was controlled by the site density of its capture antibody
(1D6) precoated on RBCs, which was measured using FITC-
labeled goat anti-mouse IgG mAb A85-1. The site density of
sPSGL-1 was measured using PE-labeled anti-PSGL-1 mAb PL1.
Since the same batch of RBCs pre-coated with the same density of
PL2 were incubated with saturating concentrations of PSGL-1 or
sPSGL-1, only one leg of PSGL-1 would be captured by PL2.
Thus, the site density for dimeric PSGL-1 was inferred to be the
same as that of monomeric sPSGL-1, whereas the density of
selectin binding-sites of PSGL-1 should be twice as that of sPSGL-
1. It is possible that a fraction of PL2 bound dimerically with the
dimeric PSGL-1 even though a saturating concentration was used.
Should this be the case, using our indirect inference would
overestimate the selectin binding sites on PSGL-1-coated RBCs.
This would increase, rather than decrease, the confidence of our
interpretation regarding the formation of dimeric bonds from the
observation of higher selectin binding to PSGL-1-coated RBCs
than to sPSGL-1-coated RBCs. The site densities of E-selectin on
CHO cells and HAECs and of L-selectin on neutrophils were
measured using anti-E-selectin mAb ES1 and anti-L-selectin mAb
DREG5.
Results
To discriminate the multimericities of E- and L-selectin on their
respective cell surfaces, we used the micropipette adhesion
frequency assay, which measures cross-junctional ligand interac-
tion with a cell surface receptor in its native membrane
environment [21,33,35]. In this 2D assay, the measured adhesion
frequency depends on both densities of the receptor and the
ligand. To control for this, we used the same batch of cells bearing
the same receptor density to interact with RBCs coated with the
same density of PL2 to capture dimeric (PSGL-1) or monomeric
(sPSGL-1). This was done for both L-selectin as well as E-selectin.
Using this in situ kinetic analysis, we determined the ability for
endothelial cell E-selectin and neutrophil L-selectin to support
dimeric interactions by comparing their binding properties with
PSGL-1 and sPSGL-1.
Interactions of sPSGL-1 and PSGL-1 with sE-selectin were
Indistinguishable Whereas those with E-selectin-Ig were
Distinct
We measured adhesion frequency Pa vs. contact duration t
curves for RBCs coated with matched densities of either sPSGL-1
or PSGL-1 and RBCs coated with sE-selectin at two site densities
(Fig. 2A and B) or with E-selectin-Ig (Fig. 2C). In contact durations
from 0.25–5 s, Pa increased with t initially and then reached
a plateau, as previously observed for E-selectin interaction with
carbohydrate ligands on HL-60 cells and Colo-205 cells [36].
Figure 1. Micropipette adhesion frequency assay. A and B. Photomicrographs of a pair of RBCs (A) or a nucleated cell (left) and a RBC (right)
(B) respectively held by two apposing pipettes. C-F. Composite of interacting molecules on respective cell surfaces. The left RBC in A was precoated
with anti-E-selectin (1D6) that captured monomeric sE-selectin or precoated with goat anti-human Ig that captured dimeric E-selectin-Ig or L-selectin-
Ig (C). The left nucleated cell in B was a PMN that expressed L-selectin (D) but could also be a HAEC or CHO cell that expressed E-selectin (E). Based on
the data of this work, L-selectin on PMN is depicted as a monomer whereas E-selectin on HAEC and CHO cell is depicted as a dimer. The right RBCs in
both A and B were precoated with anti-PSGL-1 mAb PL2 that captured dimeric membrane PSGL-1 or monomeric recombinant sPSGL-1 (F).
doi:10.1371/journal.pone.0057202.g001
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Nonspecific adhesion was controlled by adding EDTA to chelate
calcium, a divalent cation required for selectin-ligand binding.
It is evident that the two curves of (s)PSGL-1 binding to sE-
selectin were indistinguishable regardless of the sE-selectin site
densities used (Fig. 2, A and B). This indicates that monomeric sE-
selectin formed the same type of monomeric bonds with both
monomeric sPSGL-1 and dimeric PSGL-1. It also suggests that
each of the two members of dimeric PSGL-1 interacted with sE-
selectin with the same binding properties. In sharp contrast, the
two curves of (s)PSGL-1 binding to E-selectin-Ig were distinctly
different, with higher binding for the dimeric PSGL-1 than for the
monomeric sPSGL-1 at all contact durations (Fig. 2C). This
indicates that dimeric E-selectin-Ig formed monomeric bonds with
monomeric sPSGL-1 but dimeric bonds with dimeric PSGL-1.
Interactions of (s)PSGL-1 with E-selectin on HAECs and
CHO Cells Resembled those with E-selectin-Ig on RBCs
The results of the preceding section indicate that 1) dimeric
interactions required both receptor and ligand to be dimeric; 2)
dimeric interactions formed more frequently than monomeric
interactions; and 3) E-selectin had the same affinity with each leg
of dimeric PSGL-1 as with monomeric sPSGL-1. We next
compared the 2D binding of sPSGL-1 and PSGL-1 to E-selectin
on the surface of two cell types: HAECs stimulated by IL-1b to
induce native E-selectin expression at two levels (Fig. 3A and B)
and CHO cells transfected to express recombinant E-selectin
(Fig. 3C). Nonspecific adhesions were controlled by using an anti-
E-selectin mAb ES1 and the calcium chelator EDTA to inhibit
specific E-selectin binding. The adhesion frequency vs. contact
duration curves of cell surface E-selectin (Fig. 3) showed similar
kinetics as purified E-selectin-Ig coated on RBCs (Fig. 2C),
imparting confidence to applying the premises established in the
preceding section to analyze the data in this section.
Similar to Fig. 2C, binding of cell surface E-selectin to dimeric
PSGL-1 was significantly higher than that to monomeric sPSGL-1
at all contact durations tested regardless of the site densities and
cell types (Fig. 3). These data indicate that E-selectin was dimeric
on the surface of HAEC and CHO cells because it supported
dimeric interactions with PSGL-1 but monomeric interactions
with sPSGL-1.
Interactions of (s)PSGL-1 with L-selectin-Ig were Distinctly
Different
We next employed the same strategy to analyze L-selectin. In
contact durations from 0.125–2 s, RBCs bearing either of two site
densities of dimeric L-selectin-Ig adhered to RBCs bearing dimeric
PSGL-1 more frequently than to RBCs bearing monomeric
sPSGL-1 (Fig. 4). This is similar to the binding curve pattern of E-
selectin-Ig observed in Fig. 2C, confirming that dimeric vs.
monomeric interactions of (s)PSGL-1 with E-selectin-Ig could be
applied to the case of L-selectin-Ig. Thus, dimeric L-selectin-Ig
formed dimeric bonds with dimeric PSGL-1 but monomeric bonds
with monomeric sPSGL-1.
Interactions of sPSGL-1 and PSGL-1 with Neutrophil L-
selectin were Indistinguishable
We lastly compared the 2D binding of sPSGL-1 and PSGL-1 at
two matched site densities to L-selectin constitutively expressed on
human neutrophils. Nonspecific adhesions were controlled by
using RBCs precoated with an anti-PSGL-1 capturing mAb PL2
but not further incubated with either form of PSGL-1, which
abolished binding (Fig. 5). In contrast to the pattern seen with
Fig. 4, the binding curves of dimeric PSGL-1 and monomeric
sPSGL-1 were indistinguishable. These results indicate that each
of the two members of dimeric PSGL-1 interacted with L-selectin
with the same binding affinity, similar to the case of sE-selectin
(Fig. 2A and B). Like the sE-selectin data, the data in Fig. 5 also
suggest that L-selectin was a monomer on the surface of
neutrophils because it supported monomeric interactions with
both monomeric sPSGL-1 and dimeric PSGL-1.
Discussion
Using adhesion frequency measurements, we have demonstrat-
ed that E-selectin on endothelial cells or transfected CHO cells
supports dimeric interactions with dimeric PSGL-1, whereas L-
selectin on neutrophils supports only monomeric interactions with
dimeric PSGL-1.
Our observed monomeric interactions of L-selectin with PSGL-
1 are consistent with molecular stiffness measurements that L-
selectin from human tonsils reconstituted into lipid bilayers forms
monomeric bonds with PSGL-1 [14] and with biophysical
measurements that L-selectin transmembrane and cytoplasmic
domains do not dimerize in bacterial or synthetic cell membranes
[13].
Figure 2. Binding curves of two forms of recombinant E-selectin interacting with (s)PSGL-1. Adhesion frequency vs. contact duration
plots of RBCs coated with sE-selectin at site density of 126 mm22 (A) or 46 mm22 (B) or E-selectin-Ig at site density of 124 mm22 (C) interacting with
RBCs coated with sPSGL-1 (square) or PSGL-1 (triangle) at matched densities. Control for nonspecific adhesion was measured using 6 mM EDTA to
inhibit binding between sE-selectin and sPSGL-1 (A and B, cross). The different adhesion frequency levels of sE-selectin–PSGL-1 (A) and E-selectin-Ig–
sPSGL-1 (C) interactions may result from the differences in how the recombinant proteins were made, how sE-selectin and E-selectin-Ig were coated
on RBCs, and how their site densities were measured.
doi:10.1371/journal.pone.0057202.g002
Compare the Multimericity of L- and E-Selectin
PLOS ONE | www.plosone.org 4 February 2013 | Volume 8 | Issue 2 | e57202
Our observed dimeric inteactions of E-selectin with PSGL-1
differ from previous observations that E-selectin from lysates of
CHO cell transfectants reconstituted into supported lipid bilayers
forms monomeric bonds with PSGL-1, although P-selectin from
lysates of human platelets reconstituted in the same lipid bilayers
forms dimeric bonds with PSGL-1 [14]. E-selectin oligomerization
may be driven by weak noncovalent interactions that are disrupted
after detergent solubilization of membranes. P-selectin dimerizes
by noncovalent association of transmembrane domains (Ushiyama
et al 1993). These associations may require its GxxxG sequence,
a known dimerization motif [37,38]. PSGL-1 dimerizes by
noncovalent interactions between both transmembrane and
cytoplasmic domains, which are stabilized by a disulfide bond
formed immediately above the plasma membrane (Moore et al
1992, Epperson et al 2000, Miner et al 2011). Although the
transmembrane domain of E-selectin does not contain a GxxxG
sequence, our data suggest that close cis interactions of E-selectin
in the membrane enable dimeric bonds with PSGL-1. How an E-
selectin dimer is stabilized on a cell is an interesting question for
future studies.
Many adhesion molecules are constitutively expressed on the
cell surface as homodimers or oligomers. In addition to P-selectin
and PSGL-1, the b1 [39], b2 [40], b3 [41–43], and aIIb [44]
integrin subunits can form clusters. Other examples include
intercellular adhesion molecule 1 (ICAM-1) [45], platelet endo-
thelial cell adhesion molecule-1 (PECAM-1) [46], and cadherins
[47]. In addition, many cell surface receptors can be induced to
form oligomers or increase the size of preformed oligomers as
a result of intracellular signaling or ligand engagement [16].
Examples include T cell receptors [48,49], B cell receptors [50],
and Fc receptors [51,52]. Importantly, in addition to strengthen-
ing receptor–ligand interactions, oligomeric binding plays a crucial
role in many receptor-mediated signaling processes, making the
analysis of oligomeric interaction a highly relevant area of study.
Receptor oligomerization is usually demonstrated by biochem-
ical methods, e.g., chemical crosslinking, as in the case of aIIbb3
integrin [53]. Because ligand binding to adhesion receptors
provides physical linkage to anchor the cell, oligomeric interac-
tions can be analyzed by biomechanical assays. For example,
dimeric interactions between P-selectin and PSGL-1 prolong bond
lifetimes [10], increase molecular stiffness [14], and stabilize cell
rolling in shear flow [9]. Multimeric bonds have also been
characterized by increase in bond rupture forces [54–57]. The
present work has demonstrated a new method of analyzing
dimeric receptor-ligand binding by measuring 2D kinetics on the
cell membrane. However, these methods also have limitations.
One limitation is the resolution of the our methods. The
biomechanical assays based on pico-force techniques usually have
sufficiently high resolutions for mechanical variables such as bond
lifetime, molecular stiffness, cell rolling velocity, bond rupture
force, and adhesion frequency. However, they must be combined
with assays to measure site densities of the interacting molecules.
Biochemical assays sometimes suffer from inter-experimental
variations, as measurements depend on the activities of the
Figure 3. Binding curves of cell surface E-selectin interacting with (s)PSGL-1. Adhesion frequency vs. contact duration plots of HAEC
induced to express native E-selectin at 419 mm22 (A) or 258 mm22 (B) or CHO cells transfected to express recombinant E-selectin at 410 mm22 (C)
interacting with RBCs coated with matched molecular densities of sPSGL-1 (square) or PSGL-1 (triangle). Control for nonspecific adhesion was
measured using 6 mM EDTA to inhibit binding between E-selectin and sPSGL-1 (B and C, cross).
doi:10.1371/journal.pone.0057202.g003
Figure 4. Binding curves of L-selectin-Ig interacting with (s)PSGL-1. Adhesion frequency vs. contact duration plots of RBCs coated with L-
selectin-Ig at site density of 140 mm22 (A) or 112 mm22 (B) interacting with RBCs coated with matched densities of sPSGL-1 (square) or PSGL-1
(triangle).
doi:10.1371/journal.pone.0057202.g004
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reagents that can vary in each preparation. This may explain the
apparent discrepancies between Fig. 2A and B, where the
measured difference in steady-state adhesion levels is nearly two-
fold smaller than that predicted from the 2.7-fold difference in the
sE-selectin site densities. For this reason, quantitative comparison
should be done in side-by-side experiments using the same
preparation of reagents with proper controls to prevent inter-
experimental variations from negating key conclusions. This
precaution was strictly followed for the comparative data in each
panel of Figs. 2–5, ensuring the reliability of our conclusions.
To support dimeric interactions with dimeric PSGL-1, endo-
thelial cell E-selectin must form oligomers of at least two proteins.
If E-selectin forms oligomers larger than dimers on the endothelial
cell surface, our data cannot determine the actual size of the
oligomers. This limitation can be overcome by using oligomeric
ligands of larger sizes to dissect the size of E-selectin oligomers
combined with mathematical modeling to relate the binding curve
to 2D kinetics rates. With such extensions, the present method has
the potential to analyze oligomeric cross-junctional molecular
binding at the interface of two interacting cells and extract intrinsic
kinetic coefficients for such multimeric interactions.
In addition to molecular self-association, selectins cluster in
specific membrane domains through interactions with other
cellular elements. L-selectin clusters in the tips of leukocyte
microvilli, which enhances tethering under flow [58]. P- and E-
selectin cluster in clathrin-coated pits and E-selectin clusters in
lipid rafts of endothelial cells; these clusters promote slower and
more stable leukocyte rolling [59–61]. Dimerization of P-selectin
may cooperate with P-selectin clustering in clathrin-coated pits to
optimize leukocyte rolling [59,62]. For a given dimeric ligand,
whether and how effectively it forms a dimeric bond with a dimeric
receptor may depend on the on-rate and the separation distance
between the two members of the dimeric receptor, as close
proximity of the members may compensate for slow on-rate to
promote a dimeric interaction. The on-rate (but not off-rate) of 2D
receptor–ligand binding kinetics is impacted by the microtopology
[63] and stiffness [64] of the cell surface presenting the receptor as
well as the membrane anchor [20], length and orientation [65] of
the receptor and/or ligand. These provide potential mechanisms
for regulation of dimeric/oligomeric interactions. The biological
significance of cells expressing E-selectin as dimers/oligomers but
L-selectin as monomers is an important topic for future in-
vestigation.
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